Stock vs Stock Comparison

Zimmer Biomet Holdings, Inc. vs Abbott Laboratories

ABT wins the Tale of the Tape 5–4.

ZBH$84.98
ABT$86.99

🏆 Tale of the Tape

45
ZBHABT
8.6%Profitability (Net Margin)14.7%
21.3xValuation (P/E)24.0x
4.3%Efficiency (ROIC)10.1%
4/9Health (Piotroski F)5/9
2.4Safety (Altman Z)4.9
7.2%Growth (Rev YoY)5.7%
-0.24Risk (Sharpe 1Y)-1.05
0.82xBalance Sheet (D/E)0.64x
5.78%FCF Yield4.21%

Green = winner in each category. Higher is better except P/E (lower = cheaper).

Rolling Correlation

0.239
252-Day Correlation
0.267
126-Day Correlation

Low correlation — excellent diversification pair.

Fundamentals

MetricZBHABT
Market Cap$15.9B$149.1B
P/E Ratio21.3x24.0x
Forward P/E9.1x14.1x
P/B1.26x2.86x
Dividend Yield1.17%2.94%
Beta0.470.65

Quantitative Metrics

MetricZBHABT
DCF Fair Value$126.26$57.20
DCF Upside+32.4%-43.2%
Piotroski F4/95/9
Altman Z2.414.87
Beneish M-2.57-2.53
FCF Yield5.78%4.21%
Net Debt/EBITDA2.9x0.1x
ROIC4.3%10.1%
WACC7.4%9.4%
ROIC – WACC-3.0pp0.7pp
Gross Margin69.7%56.4%
Net Margin8.6%14.7%
Rev Growth YoY7.2%5.7%
Sharpe (1Y)-0.24-1.05
Max Drawdown 3Y
FCF Payout Ratio13%56%

ZBH Price

Loading chart...

ABT Price

Loading chart...

ETF Exposure

ZBH found in:

MOAT2.26%
XHE1.56%
XLV0.32%
VOE0.29%
ONEV0.28%
VHT0.26%
RSP0.18%
VO0.16%
VFVA0.12%
SCHV0.07%
VTV0.06%
IWD0.06%
SPYV0.06%
ONEO0.05%
VONV0.05%
ESGV0.04%
SPLG0.03%
SCHX0.03%
IVV0.03%
VOO0.03%
SCHB0.03%
ITOT0.03%
SPY0.03%
SPTM0.03%
URTH0.02%
QUS0.02%
VTI0.02%
VONE0.02%
ACWI0.02%

ABT found in:

IHI16.06%
IYH2.88%
XLV2.85%
VHT2.55%
DGRW1.71%
XHE1.36%
NOBL1.34%
SDY0.99%
MGV0.78%
VIG0.71%
VFMV0.69%
SCHV0.68%
VYM0.65%
VTV0.61%
IWD0.58%
QUS0.57%
SPYV0.53%
VONV0.48%
IVV0.37%
SPLG0.37%
ESGV0.36%
ITOT0.33%
SCHX0.33%
SCHB0.30%
VOO0.26%
VONE0.24%
SPY0.24%
URTH0.24%
VTI0.23%
SPTM0.22%
ACWI0.20%
RSP0.17%
VT0.14%
ONEO0.08%

More Comparisons

Quant metrics computed from financial statements and 1,200+ trading days. Correlation is Pearson coefficient on daily log returns. Not investment advice.

ZBH vs ABT: Head-to-Head Analysis

Zimmer Biomet Holdings, Inc. (ZBH) and Abbott Laboratories (ABT) represent two companies in the Healthcare sector. In our quantitative Tale of the Tape scoring, ABT leads 5–4 across nine fundamental and risk metrics including profitability, valuation, capital efficiency, and financial health.

In terms of capital efficiency, ZBH generates a return on invested capital (ROIC) of 4.3% compared to ABT's 10.1%. This suggests ABT is more effective at deploying capital to generate shareholder returns.

The 252-day rolling correlation between ZBH and ABT is 0.239, indicating low correlation, making them an effective diversification pair in a portfolio context.

ZBH appears in 29 ETFs tracked by SecuritiesDB, while ABT appears in 34 ETFs. Investors holding broad-market ETFs may already have indirect exposure to both stocks.

Frequently Asked Questions

Which stock is the better investment, ZBH or ABT?

Our quantitative analysis compares ZBH and ABT across nine fundamental dimensions. ABT wins the Tale of the Tape 5–4. However, stock selection depends on your individual risk tolerance, time horizon, and portfolio context. These metrics are computed from SEC filings and market data — they are not investment recommendations.

Are ZBH and ABT correlated?

The 252-day correlation between ZBH and ABT is 0.239. They have low correlation, offering good diversification.

How is the Tale of the Tape scored?

The Tale of the Tape compares both stocks across nine categories: profitability (net margin), valuation (P/E), efficiency (ROIC), health (Piotroski F-Score), safety (Altman Z-Score), growth (revenue YoY), risk (Sharpe ratio), leverage (debt-to-equity), and cash generation (FCF yield). The stock that wins more categories takes the overall score. Lower P/E and lower debt-to-equity count as wins.